Effect of Anti-inflammatory Diet on Inflammatory, Oxidative and Nutritional Markers in Hemodialysis Patients

NCT ID: NCT01874106

Last Updated: 2014-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effect of especial diet therapy "Anti-inflammatory Diet" on inflammatory, oxidative stress, and nutritional markers in the context of protein-energy wasting syndrome(PEW) in hemodialysis patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation Malnutrition Protein Energy Wasting Syndrome Oxidative Stress Diet Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diet therapy

The patients in this arm were educated to follow a especial type of diet (anti-inflammatory diet)in addition to nutrition counseling for 10 weeks.

Group Type EXPERIMENTAL

Diet Therapy

Intervention Type OTHER

The patients in this arm were educated to follow a especial type of diet (anti-inflammatory diet)in addition to nutrition counseling for 10 weeks.

Control Group

The patients in this arm received nutrition counseling and education in general based on their needs as a control group for 10 weeks.

Group Type OTHER

Control Group

Intervention Type OTHER

The patients in this arm received nutrition counseling and education in general based on their needs as a control group for 10 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diet Therapy

The patients in this arm were educated to follow a especial type of diet (anti-inflammatory diet)in addition to nutrition counseling for 10 weeks.

Intervention Type OTHER

Control Group

The patients in this arm received nutrition counseling and education in general based on their needs as a control group for 10 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are on hemodialysis(HD) at least two times a week for 3months or more without any internment illness or admission

Exclusion Criteria

* Hospitalization because of sepsis or surgery 3 months prior to intervention
* Cirrhosis
* Hepatitis virus infection
* Human Immunodeficiency virus infection
* Acquired Immunodeficiency Syndrome
* Active malignancy
* Active infection
* Absence of communication
* Mental Impairment
* Terminal illness
* Tube feedings
* Total parenteral nutrition
* Pregnancy
* Not previously seen by a dietitian within 3 months prior to enrollment in the study
* Not expected to be transplanted within 6 months after the enrollment in the study
* Absence of malnutrition from a cause other than end stage renal disease(ESRD)
* Psychiatric conditions, preventing adherence to intervention
* Consuming immunosuppressive drugs or taking antioxidant supplements including Vitamin E, Vitamin C, N-acetyl- cysteine (NAC), Pentoxifylline, Lipoic acid,Fish-oil extracts (omega-3 fatty acids), Soy extracts(isoflavones), Green-tea preparations, Pomegranate extracts, Grape extracts within 2 months prior to enrollment in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shiraz University of Medical Sciences

OTHER

Sponsor Role collaborator

Maryam Ekramzadeh, PhD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maryam Ekramzadeh, PhD

PhD

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zohreh Mazloom, PhD

Role: STUDY_DIRECTOR

Shiraz University of Medical Sciences, Faculty of Nutrition

Mohammadmahdi Sagheb, MD

Role: STUDY_CHAIR

Shiraz University of Medical Sciences, Nephrology Urology Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shiraz University of Medical Sciences, Department of Nutrition

Shiraz, Fars, Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

916425

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.